Towards new immunotherapies: Targeting recombinant cytokines to the immune system using live attenuated Salmonella

Vaccine

Volumn 21, Issue 7-8, 2003, Pages 798-801

  Rosenkranz, Claudia D ^a,b   Chiara, Damasia ^a   Agorio, Caroline ^a,c   Baz, Adriana ^a   Pasetti, Marcela F ^b   Schreiber, Fernanda ^a   Dematteis, Silvia ^a   Martinez, Miguel ^c   Sztein, Marcelo B ^b   Chabalgoity, Jose A ^a  

^a Universidad de la Republica Instituto de Higiene   (Uruguay)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

^c HOSPITAL DE CLÍNICAS   (Uruguay)

Author keywords

Cytokines; Gene therapy; Salomonella

Indexed keywords

ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 8; LIVE VACCINE; RECOMBINANT ANTIGEN; RECOMBINANT CYTOKINE;

ANTIBODY RESPONSE; ANTINEOPLASTIC ACTIVITY; ATTENUATION; BACTERIAL STRAIN; BACTERIUM CARRIER; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA VECTOR; EUKARYOTE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; MELANOMA; MUCOSAL IMMUNITY; NONHUMAN; PARASITOSIS; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; CYTOKINES; DRUG DELIVERY SYSTEMS; ECHINOCOCCOSIS; GENE THERAPY; GENETIC VECTORS; IMMUNOTHERAPY; MELANOMA; MICE; PLASMIDS; RECOMBINANT PROTEINS; SALMONELLA TYPHI; VACCINES, ATTENUATED;

EID: 0037472478     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00602-3     Document Type: Conference Paper

References (17)

1. Mastroeni P., Chabalgoity J.A., Dunstan S.J., Maskell D.J., Dougan G. Salmonella: immune responses and vaccines. Vet. J. 161:2001;132-164.
2. Pasetti MF, Levine MM, Sztein MB. Animal Models Paving the Way for Clinical Trials of Attenuated Salmonella Typhi Live Oral Vaccine and Live Vectors. 2002, in press.
3. Darji A., Guzman C.A., Gerstel B.P.et al. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell. 91:1997;765-775.
4. Paglia P., Medina E., Arioli I., Guzman C.A., Colombo M.P. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood. 92:1998;3172-3176.
5. Pickett T.E., Pasetti M.F., Galen J.E., Sztein M.B., Levine M.M. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated salmonella enterica serovar typhi strains as live mucosal vaccines and as live vectors. Infect. Immun. 68:2000;205-213.
6. Chabalgoity J.A., Khan C.M., Nash A.A., Hormaeche C.E. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Mol. Microbiol. 19:1996;791-801.
7. Galen J.E., Levine M.M. Can a 'flawless' live vector vaccine strain be engineered? Trends Microbial. 9:2001;372-376.
8. Tacket C.O., Sztein M.B., Losonsky G.A.et al. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect. Immun. 65:1997;452-456.
9. Tacket C.O., Sztein M.B., Wasserman S.S.et al. Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in US volunteers. Infect. Immun. 68:2000;1196-1201.
10. Pasetti M.F., Anderson R.J., Noriega F.R., Levine M.M., Sztein M.B. Attenuated ΔguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses. Clin. Immunol. 92:1999;76-89.
11. Okamura H, Tsutsui H, Kashiwamura S, Yoshimoto T, Nakanishi K. IL-18. In: Cytokine Reference, vol. 1: Ligands. San Diego: Academic Press; 2001. p. 337.
12. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19:2001;423-474.
13. Urashima M., Suzuki H., Yuza Y., Akiyama M., Ohno N., Eto Y. An oral CD40 ligand gene therapy against lymphoma using attenuated Salmonella typhimurium. Blood. 95:2000;1258-1263.
14. Yuhua L., Kunyuan G., Hui C., Yengmei X., Chaoyang S., Xun T., Daming R. Oral cytokine gene therapy against murine tumor using attenuated Salmonella typhimurium. Int. J. Cancer. 94:2001;438-444.
15. Missol E., Sochanik A., Szalaa S. Introduction of murine IL-4 gene into B16(F10) melanoma tumor by direct gene transfer with DNA-liposome complexes. Cancer Lett. 97:1995;189-193.
16. Cho D., Kim T.G., Lee W.et al. Interleukin-18 and the costimulatory molecule B7-1 have a synergistic anti-tumor effect on murine melanoma; implication of combined immunotherapy for poorly immunogenic malignancy. J. Invest Dermatol. 114:2000;928-934.
17. Pawelek J.M., Low K.B., Bermudes D. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res. 57:1997;4537-4544.